STRAHLENTHERAPIE UND ONKOLOGIE

Scope & Guideline

Exploring the forefront of oncology and radiological science.

Introduction

Explore the comprehensive scope of STRAHLENTHERAPIE UND ONKOLOGIE through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore STRAHLENTHERAPIE UND ONKOLOGIE in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN0179-7158
PublisherSPRINGER HEIDELBERG
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1986 to 2024
AbbreviationSTRAHLENTHER ONKOL / Strahlenther. Onkol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY

Aims and Scopes

The journal 'STRAHLENTHERAPIE UND ONKOLOGIE' focuses on advancing the field of radiation therapy and oncology through a diverse range of research topics. It aims to publish high-quality studies that contribute to the understanding and application of radiotherapy in various cancer types, emphasizing the integration of innovative technologies and treatment modalities.
  1. Radiotherapy Techniques and Innovations:
    The journal consistently publishes research on novel radiotherapy techniques, including intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), and proton therapy, highlighting advancements that improve treatment precision and patient outcomes.
  2. Clinical Outcomes and Toxicity Management:
    A significant focus is placed on clinical studies that evaluate the effectiveness of various treatment regimens, including chemoradiotherapy, and their associated toxicities, with an emphasis on optimizing patient care and quality of life.
  3. Personalized and Adaptive Radiotherapy:
    Research exploring personalized treatment approaches, including the use of AI in treatment planning and adaptive radiotherapy techniques, is a core area of interest, addressing the need for tailored therapies based on individual patient characteristics.
  4. Integration of Imaging and Radiomics:
    The journal highlights the role of advanced imaging techniques, such as PET/CT and MRI, along with radiomics, in predicting treatment responses and outcomes, illustrating the growing intersection between imaging and radiotherapy.
  5. Multidisciplinary Approaches and Patient-Centered Care:
    Emphasizing the importance of a multidisciplinary approach, the journal features studies that integrate insights from various specialties, including oncology, surgery, and palliative care, to enhance patient management and treatment strategies.
The journal is witnessing a dynamic evolution in its research themes, with several emerging trends that reflect the latest advancements and priorities in the field of radiation oncology. This section outlines the currently trending research areas.
  1. Artificial Intelligence and Machine Learning:
    There is a growing trend towards the application of AI and machine learning techniques in radiation therapy, from treatment planning to predictive modeling, enhancing precision and efficiency in patient management.
  2. Immunotherapy and Radiotherapy Combinations:
    Research exploring the synergistic effects of combining immunotherapy with radiotherapy is on the rise, reflecting a shift towards integrated treatment strategies that optimize clinical outcomes for cancer patients.
  3. Patient-Centered Approaches and Quality of Life Assessments:
    Increasing attention is being paid to patient-reported outcomes and quality of life assessments in treatment protocols, emphasizing the importance of patient perspectives and experiences in oncology care.
  4. Real-World Data and Comparative Effectiveness Research:
    There is a notable trend towards utilizing real-world data to assess treatment effectiveness and safety, providing insights that complement clinical trial findings and inform clinical practice.
  5. Sustainability and Cost-Effectiveness in Oncology:
    Emerging themes around sustainability in radiation oncology practices and the evaluation of cost-effectiveness of various treatment modalities are gaining traction, reflecting broader healthcare priorities.

Declining or Waning

While the journal continues to thrive in various research areas, some themes appear to be losing prominence in recent publications. This section identifies these waning scopes, reflecting shifts in research focus within the field of radiation oncology.
  1. Traditional Radiation Techniques:
    There is a noticeable decline in studies focusing solely on conventional radiation therapy methods without the integration of advanced technologies or personalized approaches, as the field shifts towards more innovative and tailored treatment strategies.
  2. Descriptive Studies without Clinical Application:
    Research that is primarily descriptive and lacks direct clinical application or implications seems to be decreasing, as the journal increasingly favors studies that demonstrate practical outcomes and advancements in patient care.
  3. Longitudinal Studies on Historical Data:
    The emphasis on historical data analysis and retrospective studies without new insights or technological advancements appears to be waning, with a greater focus now on contemporary clinical trials and innovative methodologies.

Similar Journals

Breast Cancer

Empowering breakthroughs in oncology and pharmacology.
Publisher: SPRINGER JAPAN KKISSN: 1340-6868Frequency: 6 issues/year

Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.

Radiology and Oncology

Leading the way in diagnostic imaging and cancer research.
Publisher: SCIENDOISSN: 1318-2099Frequency: 4 issues/year

Radiology and Oncology is a prominent open access journal that has been instrumental in advancing the fields of radiology and oncology since its inception in 1992. Published by SCIENDO in Germany, this journal aims to disseminate high-quality research articles, reviews, and case studies that address critical issues in diagnostic imaging and cancer treatment. As of 2023, it holds a commendable impact factor within the Q2 category for Radiology, Nuclear Medicine, and Imaging, and a Q3 standing in the field of Oncology—reflecting its importance in these critical areas of medicine. With a focus on promoting innovative research and interdisciplinary collaboration, Radiology and Oncology is indexed in Scopus, where it ranks #122 among 333 in its category and #187 among 404 in Oncology, showcasing its wide-reaching impact and relevance. The journal is fully open access since 2007, ensuring that vital research is accessible to the global medical community and fostering advancements in patient care strategies and therapeutic methodologies. By providing a platform for the latest developments and discoveries, Radiology and Oncology is a pivotal resource for researchers, clinicians, and students dedicated to improving outcomes in cancer care through innovative imaging techniques.

MEDICAL PHYSICS

Exploring Innovations in Medical Imaging and Treatment
Publisher: WILEYISSN: 0094-2405Frequency: 12 issues/year

MEDICAL PHYSICS, published by WILEY, stands as a leading journal in the fields of biophysics, medicine, and radiology, boasting an impressive impact factor and classified within the prestigious Q1 category across multiple relevant domains. With its ISSN 0094-2405 and E-ISSN 2473-4209, the journal has been a vital resource since its inception in 1974, leading the discourse well into 2024. Hailing from the United States, MEDICAL PHYSICS serves a diverse academic audience, comprising researchers, clinicians, and students eager to engage with the latest advancements and methodologies. The journal’s authoritative presence is underscored by its Scopus rankings, placing it among the top percentile in both Medicine and Biophysics, marking it as an essential scholarly platform for innovative research and critical reviews. While not currently an Open Access journal, its commitment to curating high-quality articles ensures that readers can access groundbreaking insights into medical imaging, treatment protocols, and the theoretical underpinnings of medical physics. Explore the intersection of technology and healthcare through the esteemed pages of MEDICAL PHYSICS.

Journal of Radiotherapy in Practice

Elevating Standards in Radiotherapy Through Peer-reviewed Insights
Publisher: CAMBRIDGE UNIV PRESSISSN: 1460-3969Frequency: 4 issues/year

Journal of Radiotherapy in Practice is a peer-reviewed journal published by Cambridge University Press, focusing on the evolving field of radiotherapy and its application in clinical practice. With ISSN 1460-3969 and E-ISSN 1467-1131, this journal serves as a critical platform for researchers, clinicians, and students in oncology and radiology, providing vital insights into treatment methodologies, patient care, and innovative practices. Although indexed in Q4 quartiles for both Oncology and Radiology, Nuclear Medicine and Imaging, the journal plays an essential role in disseminating clinical findings and advancing the science of radiotherapy since its inception in 1999. Authors are encouraged to contribute their research, case studies, and reviews that align with the journal's objectives, fostering a collaborative environment for sharing knowledge. Despite its current rankings, the journal aims to enhance its impact and visibility in the scientific community, thereby enriching professional practice and patient outcomes in the realm of radiotherapy.

Breast Journal

Fostering collaboration for a healthier tomorrow.
Publisher: WILEY-HINDAWIISSN: 1075-122XFrequency: 1 issue/year

The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.

JOURNAL OF RADIATION RESEARCH

Exploring the frontiers of health and toxicology in radiation.
Publisher: OXFORD UNIV PRESSISSN: 0449-3060Frequency: 6 issues/year

JOURNAL OF RADIATION RESEARCH, published by Oxford University Press, is a prominent peer-reviewed journal focusing on the diverse fields of radiation science, including health, toxicology, and radiology. Since its inception in 1960, this open-access journal has provided a critical platform for the dissemination of high-quality research, making it accessible to a global audience of researchers, professionals, and students. With a consistent track record, the journal holds an impressive impact factor and is categorized in Q2 of Radiation studies and Q3 in Health and Toxicology as per the 2023 rankings, reflecting its influential role in shaping contemporary discourse in the field. The journal also boasts notable rankings within Scopus, further underscoring its importance in advancing knowledge and innovations related to radiation. Spanning from 1960 to 2024, the JOURNAL OF RADIATION RESEARCH remains at the forefront of scientific exploration and is essential reading for anyone committed to advancing the understanding of radiation and its effects.

INTERNATIONAL JOURNAL OF HYPERTHERMIA

Connecting researchers to enhance hyperthermia applications globally.
Publisher: TAYLOR & FRANCIS LTDISSN: 0265-6736Frequency: 8 issues/year

INTERNATIONAL JOURNAL OF HYPERTHERMIA, published by Taylor & Francis Ltd, is a leading peer-reviewed journal dedicated to advancing the field of hyperthermia and its applications in medical science, particularly within cancer research and related disciplines. With an ISSN of 0265-6736 and an E-ISSN of 1464-5157, this journal has been a vital resource since its establishment in 1985, offering a platform for innovative research and clinical applications aimed at improving treatment outcomes. The journal is recognized with a Q2 category ranking in several fields, including Cancer Research and Physiological Medicine, reflecting its significant contribution to scientific knowledge and clinical practices. Furthermore, it has been Open Access since 2019, ensuring that cutting-edge research is accessible to a global audience. By facilitating the exchange of ideas and fostering collaborations among researchers, professionals, and students, the INTERNATIONAL JOURNAL OF HYPERTHERMIA serves as an essential resource in the quest to exploit hyperthermia’s full potential in therapeutic settings.

Tumori Journal

Leading the Way in Cancer Understanding and Care.
Publisher: SAGE PUBLICATIONS LTDISSN: 0300-8916Frequency: 6 issues/year

Tumori Journal is a distinguished publication in the field of oncology, dedicated to advancing the understanding and treatment of cancer since its inception in 1946. Published by SAGE Publications Ltd, this Italian journal serves as a pivotal platform for researchers, clinicians, and academicians to disseminate cutting-edge findings in cancer research and related areas of medicine. With an impressive record of contributions spanning multiple decades, Tumori Journal aims to foster collaboration and dialogue among professionals in the oncology community. Although classified in the Q4 category for Cancer Research and the Q3 category for both Medicine (miscellaneous) and Oncology as of 2023, the journal continues to draw interest with its rigorous peer-review process and commitment to quality. Researchers are encouraged to explore innovative methodologies and share impactful clinical insights through the journal, which also ranks within the top tiers of Scopus metrics for oncology and cancer research domains. With a growing emphasis on accessible research, Tumori Journal remains an essential resource in the continuous fight against cancer.

Physics & Imaging in Radiation Oncology

Pioneering Insights at the Intersection of Physics and Oncology
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Physics & Imaging in Radiation Oncology is a premier journal dedicated to advancing the interdisciplinary field of radiation oncology through innovative research and imaging technologies. Published by Elsevier, this open-access journal has made its mark since its inception in 2017, ensuring that groundbreaking findings are accessible to a broad audience. With a strong focus on the integration of physics, imaging techniques, and oncology, the journal occupies esteemed positions in the academic landscape, ranking in the top quartile for Radiation and Radiology, Nuclear Medicine and Imaging as of 2023. The journal serves as a platform for researchers, professionals, and students to share insights and foster collaboration, ultimately improving patient outcomes through enhanced imaging and treatment modalities. Based in Ireland and operating from Radarweg 29, 1043 NX Amsterdam, Netherlands, the journal aims to bridge the gap between theoretical physics and practical applications in clinical settings.

CLINICAL ONCOLOGY

Elevating Clinical Practice in Oncology and Radiology
Publisher: ELSEVIER SCIENCE LONDONISSN: 0936-6555Frequency: 6 issues/year

Clinical Oncology is a prestigious peer-reviewed journal published by Elsevier Science London, focusing on the dynamic fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an impressive impact factor reflecting its high-quality research contributions, the journal is ranked in the second quartile for oncology and the first quartile for radiology, underscoring its importance in advancing clinical knowledge and practice. Established in 1975, Clinical Oncology offers researchers, healthcare professionals, and students robust access to cutting-edge studies, reviews, and clinical trials that drive innovation and improve patient care. Based in the United Kingdom, the journal plays a vital role in disseminating significant findings, fostering collaboration, and enhancing education in the biosciences, particularly for those committed to addressing the challenges in cancer treatment and diagnostics. Given its rigorous selection criteria and broad readership, Clinical Oncology remains an essential resource for anyone dedicated to the fields of oncology and radiology.